These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18436307)

  • 1. Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study.
    De Socio GV; Parruti G; Quirino T; Ricci E; Schillaci G; Adriani B; Marconi P; Franzetti M; Martinelli C; Vichi F; Penco G; Sfara C; Madeddu G; Bonfanti P;
    J Infect; 2008 Jul; 57(1):33-40. PubMed ID: 18436307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is estimated cardiovascular risk higher in HIV-infected patients than in the general population?
    De Socio GV; Martinelli L; Morosi S; Fiorio M; Roscini AR; Stagni G; Schillaci G
    Scand J Infect Dis; 2007; 39(9):805-12. PubMed ID: 17701720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and Framingham risk score for prediction of cardiovascular events in Caribbean Indian patients with blood glucose abnormalities.
    Jaquet A; Deloumeaux J; Dumoulin M; Bangou J; Donnet JP; Foucan L
    Diabetes Metab; 2008 Apr; 34(2):177-81. PubMed ID: 18353700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of renal damage with cardiovascular diseases is independent of individual cardiovascular risk profile in hypertension: data from the Italy - Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study.
    Sciarretta S; Valenti V; Tocci G; Pontremoli R; Rosei EA; Ambrosioni E; Costa V; Leonetti G; Pessina AC; Trimarco B; Chin D; Paneni F; Deferrari G; Ferrucci A; Volpe M
    J Hypertens; 2010 Feb; 28(2):251-8. PubMed ID: 19812502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Framingham risk score despite high prevalence of metabolic syndrome in asymptomatic North-Indian population.
    Bansal M; Shrivastava S; Mehrotra R; Agarwal V; Kasliwal RR
    J Assoc Physicians India; 2009 Jan; 57():17-22. PubMed ID: 19753753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: results from the HERMES study.
    De Socio GV; Martinelli C; Ricci E; Orofino G; Valsecchi L; Vitiello P; Martinelli L; Quirino T; Maggi P; Bonfanti P;
    Int J STD AIDS; 2010 Apr; 21(4):267-72. PubMed ID: 20378899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients. Part II: gender differences.
    Neumann T; Woiwod T; Neumann A; Ross B; Von Birgelen C; Volbracht L; Brockmeyer NH; Gerken G; Erbel R
    Eur J Med Res; 2004 Feb; 9(2):55-60. PubMed ID: 15090290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease.
    Guaraldi G; Ventura P; Garlassi E; Orlando G; Squillace N; Nardini G; Stentarelli C; Zona S; Marchini S; Moriondo V; Tebas P
    HIV Med; 2009 Jan; 10(1):28-34. PubMed ID: 19125962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study.
    Lichtenstein KA; Armon C; Buchacz K; Chmiel JS; Buckner K; Tedaldi EM; Wood K; Holmberg SD; Brooks JT;
    Clin Infect Dis; 2010 Aug; 51(4):435-47. PubMed ID: 20597691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study.
    Glass TR; Ungsedhapand C; Wolbers M; Weber R; Vernazza PL; Rickenbach M; Furrer H; Bernasconi E; Cavassini M; Hirschel B; Battegay M; Bucher HC;
    HIV Med; 2006 Sep; 7(6):404-10. PubMed ID: 16903986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic syndrome, an epidemic among HIV-infected patients on HAART.
    Jevtović DJ; Dragović G; Salemović D; Ranin J; Djurković-Djaković O
    Biomed Pharmacother; 2009 Jun; 63(5):337-42. PubMed ID: 18996676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients: part I. Differences due to the acquisition of HIV-infection.
    Neumann T; Woiwoid T; Neumann A; Miller M; Ross B; Volbracht L; Brockmeyer N; Gerken G; Erbel R
    Eur J Med Res; 2003 Jun; 8(6):229-35. PubMed ID: 12911871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipodystrophy - a sign for metabolic syndrome in patients of the HIV-HEART study.
    Potthoff A; Brockmeyer NH; Gelbrich G; Neuhaus K; Esser S; Reinsch N; Hower M; Mostardt S; Neumann A; Neumann T;
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):92-8. PubMed ID: 20002869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between white blood cell count and Framingham Risk Score in asymptomatic men.
    Orakzai SH; Orakzai RH; Nasir K; Carvalho JA; Blumenthal RS; Santos RD
    Arch Med Res; 2007 May; 38(4):386-91. PubMed ID: 17416284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total cardiovascular risk estimation in Romania. Data from the SEPHAR study.
    Dorobantu M; Bădilă E; Ghiorghe S; Darabont RO; Olteanu M; Flondor P
    Rom J Intern Med; 2008; 46(1):29-37. PubMed ID: 19157268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk in patients with bipolar disorder.
    Garcia-Portilla MP; Saiz PA; Bascaran MT; Martínez A S; Benabarre A; Sierra P; Torres P; Montes JM; Bousoño M; Bobes J;
    J Affect Disord; 2009 Jun; 115(3):302-8. PubMed ID: 18954911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimating cardiovascular risk in Spain using different algorithms].
    Comín E; Solanas P; Cabezas C; Subirana I; Ramos R; Gené-Badía J; Cordón F; Grau M; Cabré-Vila JJ; Marrugat J
    Rev Esp Cardiol; 2007 Jul; 60(7):693-702. PubMed ID: 17663853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.